Bjarne Anker Jensen
- Hematology top 2%
- Blood groups and transfusion 3
- Acute Myeloid Leukemia Research 2
- Platelet Disorders and Treatments 2
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Chronic Lymphocytic Leukemia Research 2
- Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases 2
- Lymphoma Diagnosis and Treatment 2
-
- Eosinophilic Disorders and Syndromes 2
- Co-authors
- Hans Carl HasselbalchHenrik BirgensHans Torben Mourits‐AndersenLars KjeldsenTobias Wirenfeldt KlausenNielsaage Tøffner ClausenBjarne Bach PedersenJ Pedersen-Bjergaard
In The Last Decade
Bjarne Anker Jensen
10 papers receiving 624 citations
Peers
Comparison fields: 5 of 52
- Hematology 460
- Genetics 217
- Pathology and Forensic Medicine 136
- Rheumatology 63
- Nephrology 26
Countries citing papers authored by Bjarne Anker Jensen
This map shows the geographic impact of Bjarne Anker Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjarne Anker Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjarne Anker Jensen more than expected).
Fields of papers citing papers by Bjarne Anker Jensen
This network shows the impact of papers produced by Bjarne Anker Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjarne Anker Jensen. The network helps show where Bjarne Anker Jensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bjarne Anker Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 125 | |
| 2 | 2005 | 129 | |
| 3 | 2005 | 104 | |
| 4 | 2003 | 33 | |
| 5 | 2002 | 41 | |
| 6 | 2002 | 24 | |
| 7 | 2001 | 99 | |
| 8 | 1990 | 30 | |
| 9 | Plasma tetranectin in healthy male and female individuals, measured by enzyme-linked immunosorbent assay. | 1987 | 36 |
| 10 | 1986 | 0 | |
| 11 | 1986 | 17 |
About Bjarne Anker Jensen
Bjarne Anker Jensen is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 11 papers that have together received 638 indexed citations. Recurring topics across this work include Blood groups and transfusion (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Platelet Disorders and Treatments (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (460 citations), Genetics (217 citations) and Pathology and Forensic Medicine (136 citations). Bjarne Anker Jensen has collaborated with scholars based in Denmark, Iceland and Norway. Frequent co-authors include Hans Carl Hasselbalch, Henrik Birgens, Hans Torben Mourits‐Andersen, Lars Kjeldsen, Tobias Wirenfeldt Klausen, Nielsaage Tøffner Clausen, Bjarne Bach Pedersen, J Pedersen-Bjergaard, Debes Hammershaimb Christiansen and Peter Ernst. Their work appears in journals such as American Journal of Hematology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Haematology, European Journal Of Haematology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.